Abstract
Objective To study the clinical impact of prophylactic octreotide on patients who underwent pancreatic resection using evidence-based medicine. Methods Electronic databases which included the Cochrane library, Pubmed and Embase were searched. A Meta-analysis of all randomized controlled trials (RCTs) on the clinical impact of prophylactic octreotide on pancreatic resection was performed. The evaluation of the literature quality and the effective of the data were based on the Cochrane Handbook for systematic reviews. The Review Manager 5.3 was used for the meta-analysis. Results 13 studies which involved 2 108 patients were included into this study, with 1 057 patients in the octreotide group and 1 051 patients in the control group. Meta-analysis revealed that the rates of pancreatic fistula (PF), including Class A, B and C and the total postoperative complication rate were lower in patients treated with prophylactic octreotide than those without octreotide (14.7% vs. 21.6%, RR=0.67, 95%CI: 0.56-0.81, P 0.05). Conclusion Octreotide reduced PF including Class A, B and C and decreased the total complication rate, but did not reduce the clinically relevant fistulas and perioperative mortality. Key words: Pancreatic fistula; Pancreatic resection; Octreotide; Complications; Meta-analysis
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
